[ad_1] WASHINGTON – The FDA has approved the inhalation suspension of insamed amikacin liposomes (Arikayce) for a limited population of patients with some type of non-tuberculous mycobacterial lung infection, said the agency …
Read More »FDA approves inhaled amikacin for non-tuberculous lung infection
